Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03932630

Looping Whilst Restricting Carbohydrates

Looping Whilst Restricting Carbohydrates (LINEAR) - a Randomised Two-Period Crossover Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To investigate the efficacy, safety and utility of hybrid closed-loop glucose control during a low carbohydrate vs. iso-energetic balanced diet in individuals with type 1 diabetes.

Detailed description

Closed-loop systems combining an insulin pump, a glucose sensor and a dosing algorithm that adjusts insulin delivery in a glucose-responsive manner achieve significantly better glucose control than conventional therapy in type 1 diabetes. Achieving satisfactory postprandial glucose control, however, continues to be challenging. The main limitation is the delayed pharmacokinetics and -dynamics of subcutaneously administered insulin with peak actions between 1 and 2 hours. Conversely, glucose levels typically rise within 10minutes following carbohydrate intake. This mismatch largely explains the inability of current closed-loop systems to control postprandial glucose excursions and the increased risk of late postprandial hypoglycaemia in response to both user-derived meal bolus administration and reactive algorithm-driven insulin infusion. Restricting carbohydrate may therefore significantly improve post-prandial glucose control whilst reducing hypoglycaemia. The efficacy of hybrid closed-loop operation in individuals with type 1 diabetes adhering to a low carbohydrate compared to a iso-caloric balanced diet has not been investigated to date.

Conditions

Interventions

TypeNameDescription
OTHERLow carbohydrate dietThe study intervention will be an eucaloric low carbohydrate diet (15-20 % of carbohydrates) for 2 weeks.
OTHERbalanced dietThe control intervention will be a energy-matched balanced diet (50 % of carbohydrates) for 2 weeks.

Timeline

Start date
2019-12-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2019-05-01
Last updated
2022-12-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03932630. Inclusion in this directory is not an endorsement.